Discontinuation of biologic therapy in severe asthma: Evidence and strategies for safe withdrawal: A scoping review
Introduction: Severe asthma is characterized by poor disease control despite the use of high-dose inhaled corticosteroids and long-acting bronchodilators. Biologic therapies have revolutionized its management, allowing some patients to achieve remission. However, uncertainty remains regarding the op...
Saved in:
| Main Authors: | Johanna Ramirez-Villamizar, MD, Ciro D. Ibarra-Enríquez, MD, Juan Sebastián Galindo-Sánchez, MD, Carlos Serrano-Reyes, MD, Liliana Fernández-Trujillo, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | World Allergy Organization Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455125000845 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical, functional, and laboratory course of children and adolescents with severe asthma after discontinuation of biologics
by: Valentina Agnese Ferraro, et al.
Published: (2025-08-01) -
Corticosteroid use beyond 1-year post heart transplantation is associated with worse outcomes: A contemporary analysis of the ISHLT registry
by: Abhishek Jaiswal, MD, et al.
Published: (2025-05-01) -
Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series
by: Shigesato Inoue, MD, et al.
Published: (2025-05-01) -
The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
by: Raqeeb Mahmood, et al.
Published: (2024-02-01) -
Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis
by: Andri Rennwald, et al.
Published: (2025-01-01)